速递|体重减轻7.7%,歌礼制药口服GLP-1美国二期临床试验数据发布

GLP1减重宝典
Dec 11, 2025

整理 | GLP1减重宝典内容团队歌礼制药公布了其口服 GLP-1 管线产品 ASC30 的最新临床结果。在竞争激烈的口服减重药赛道中,该药物在最高剂量下实现了 7.7% 的体重下降。这项在美国开展的 II 期研究共纳入 125 名肥胖或超重且伴随至少一种体重相关并发症的受试者,评估了 ASC30 每日一次的三种剂量方案。根据 12 月 8 日发布的数据,20mg、40mg 和 60mg 剂量在第...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10